Involvement of 5-HT1A receptor mechanisms in the inhibitory effects of methamphetamine on photic responses in the rodent suprachiasmatic nucleus

被引:6
|
作者
Moriya, T
Yamanouchi, S
Fukushima, T
Shimazoe, T
Shibata, S
Watanabe, S
机构
[1] WASEDA UNIV,SCH HUMAN SCI,DEPT PHARMACOL,TOKOROZAWA,SAITAMA 359,JAPAN
[2] KYUSHU UNIV,DEPT PHARMACOL,FAC PHARMACEUT SCI,FUKUOKA 81282,JAPAN
关键词
circadian rhythm; suprachiasmatic nucleus; methamphetamine; NAN-190; 5-HT1A receptor; serotonin;
D O I
10.1016/S0006-8993(96)00860-8
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
We examined the role of serotonin IA (5-HT1A) receptors in the inhibitory effects of methamphetamine (MA) on photic entrainment to the circadian pacemaker in the suprachiasmatic nucleus (SCN) of rodents. MA inhibited optic nerve stimulation-evoked field potential in the SCN, light-induced Fos expression in the SCN and light-induced phase shift of hamster wheel-running rhythm. NAN-190, a 5-HT1A receptor antagonist, eliminated the inhibitory effects of MA. NAN-190 has also been reported to antagonize alpha 1 adrenergic receptors. However, prazosin, which selectively antagonizes alpha(1) adrenergic receptors, did not affect the inhibitory action of RIA on light-induced Fos expression. In addition, parachloroamphetamine, which is known to be a 5-HT releaser, dose-dependently inhibited light-induced phase shift of wheel-running rhythm. These findings suggest that elevation of endogenous 5-HT levels by RIA inhibits the photic entraining responses of the circadian pacemaker in the SCN via 5-HT1A receptor stimulation of the 5-HT released by MA.
引用
收藏
页码:261 / 267
页数:7
相关论文
共 50 条
  • [41] Corticosterone responses in 5-HT1B receptor knockout mice to stress or 5-HT1A receptor activation are normal
    J. Adriaan Bouwknecht
    Jan van der Gugten
    Theo H. Hijzen
    Robert A.A. Maes
    René Hen
    Berend Olivier
    Psychopharmacology, 2001, 153 : 484 - 490
  • [42] Nucleus incertus contributes to an anxiogenic effect of buspirone in rats: Involvement of 5-HT1A receptors
    Kumar, Jigna Rajesh
    Rajkumar, Ramamoorthy
    Lee, Liying Corinne
    Dawe, Gavin S.
    NEUROPHARMACOLOGY, 2016, 110 : 1 - 14
  • [43] (-)-PENBUTOLOL AS A BLOCKER OF CENTRAL 5-HT1A RECEPTOR-MEDIATED RESPONSES
    HJORTH, S
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1992, 222 (01) : 121 - 127
  • [44] Involvement of the serotonergic type 1A (5-HT1A) receptor in the agranular insular cortex in the consolidation of memory for inhibitory avoidance in rats
    Souza, TME
    Rodrigues, C
    Souza, MM
    Vinadé, E
    Coitinho, A
    Choi, H
    Izquierdo, I
    BEHAVIOURAL PHARMACOLOGY, 2001, 12 (05): : 349 - 353
  • [45] Involvement of the 5-HT1A and 5-HT1B serotonergic receptor subtypes in sexual arousal in male mice
    Popova, NK
    Amstislavskaya, TG
    PSYCHONEUROENDOCRINOLOGY, 2002, 27 (05) : 609 - 618
  • [46] DIFFERENT EFFECTS ON THE RESPONSES OF FUNCTIONAL PRESYNAPTIC AND POSTSYNAPTIC 5-HT1A RECEPTORS BY REPEATED TREATMENT OF RATS WITH THE 5-HT1A RECEPTOR AGONIST 8-OH-DPAT
    LARSSON, LG
    RENYI, L
    ROSS, SB
    SVENSSON, B
    ANGEBYMOLLER, K
    NEUROPHARMACOLOGY, 1990, 29 (02) : 85 - 91
  • [47] BIMT-17, A 5-HT1A RECEPTOR AGONIST 5-HT2A RECEPTOR ANTAGONIST, DIRECTLY ACTIVATES POSTSYNAPTIC 5-HT INHIBITORY RESPONSES IN THE RAT CEREBRAL-CORTEX
    BORSINI, F
    CECI, A
    BIETTI, G
    DONETTI, A
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1995, 352 (03) : 283 - 290
  • [48] Effects of the 5-HT1A receptor agonist flesinoxan in panic disorder
    vanVliet, IM
    Westenberg, HGM
    denBoer, JA
    PSYCHOPHARMACOLOGY, 1996, 127 (02) : 174 - 180
  • [49] Separate and combined effects of fluoxetine and a 5-HT1A receptor agonist or antagonist on 5-HT1A and 5-HT1B autoreceptor activity in the rat brain
    Shalom, G
    Gur, E
    Van de Kar, LD
    Lerer, B
    Newman, ME
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2004, 14 : S15 - S16
  • [50] Involvement of the 5-HT1A subtype receptor in the neonatal organization of agonistic behaviour in the rat
    Albonetti, E
    Gonzalez, MI
    Siddiqui, A
    Wilson, CA
    Farabollini, F
    PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1996, 54 (01) : 189 - 193